Table 3. Self-report fatigue and physical function according to chemotherapy status in breast cancer survivors.
| Measures, mean (SD) | Chemotherapy | No Chemotherapy | P-value |
|---|---|---|---|
| Fatigue disruption index* | 15.15 (16.23) | 11.10 (13.04) | 0.311 |
| Late-life function score (raw) | 62.07 (9.69) | 64.64 (13.31) | 0.413 |
| Late-life function score (scaled) | 55.00 (6.30) | 55.60 (6.40) | 0.716 |
| Short-form-36 domains | |||
| Physical functioning | 57.96 (34.22) | 72.24 (23.81) | 0.074 |
| Physical role functioning | 57.41 (42.07) | 73.28 (34.67) | 0.128 |
| Bodily pain | 64.26 (26.53) | 70.17 (26.78) | 0.410 |
| General health | 54.44 (17.70) | 56.72 (14.26) | 0.599 |
| Vitality | 54.23 (24.15) | 58.79 (24.95) | 0.338 |
| Social role functioning | 75.00 (25.94) | 85.34 (17.69) | 0.085 |
| Emotional role functioning | 75.80 (33.20) | 77.80 (33.20) | 0.841 |
| Mental health | 80.00 (12.13) | 81.43 (12.98) | 0.678 |
| Physical composite score | 40.50 (10.67) | 45.61 (8.30) | 0.054 |
| Mental composite score | 52.48 (9.87) | 52.67 (7.69) | 0.877 |
*
The disruption index is estimated from general level of activity, ability to bathe and dress, normal work activity, ability to concentrate, relations with others, enjoyment of life, and mood.